Carbimazole induced eosinophilic granulomatous vasculitis localized to the stomach

Journal of Internal Medicine

Volumn 258, Issue 2, 2005, Pages 191-195

  Seve P ^a   Stankovic, K ^a   Michalet, V ^b   Vial, T ^c   Scoazec, J Y ^d   Broussolle, Christiane ^a  

^a HÔTEL DIEU   (France)

^b CROIX ROUSSE HOSPITAL   (France)

^c Regional Pharmacoviligance Center   (France)

^d EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

Carbimazole; Churg Strauss syndrome; Eosinophilic granulomatous vasculitis; Stomach; Vasculitis

Indexed keywords

ALBENDAZOLE; CARBIMAZOLE; PROPRANOLOL;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; EOSINOPHILIA; GASTROSCOPY; GRANULOMATOUS VASCULITIS; GRAVES DISEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; STOMACH BIOPSY; STOMACH MUCOSA; STOMACH TUMOR;

ADULT; ANTITHYROID AGENTS; CARBIMAZOLE; DIAGNOSIS, DIFFERENTIAL; EOSINOPHILIA; GASTRITIS; GRANULOMA; GRAVES DISEASE; HUMANS; MALE; STOMACH NEOPLASMS; VASCULITIS;

EID: 22644445348     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2005.01525.x     Document Type: Article

References (32)

1. Bartalena L, Bogazzi F, Martino E. Adverse effects of thyroid hormone preparations and antithyroid drugs. Drug Saf 1996; 15: 53-63.
2. Gunton JE, Stiel J, Clifton-Bligh P, Wilmshurst E, McElduff A. Prevalence of positive anti-neutrophil cytoplasmic antibody (ANCA) in patients receiving anti-thyroid medication. Eur J Endocrinol 2000; 142: 587-90.
3. Sera N, Ashizawa K, Ando T et al. Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves' disease. Thyroid 2000; 10: 595-9.
4. Gao Y, Zhao MH, Guo XH, Xin G, Wang HY. The prevalence and target antigens of antithyroid drugs induced antineutrophil cytoplasmic antibodies (ANCA) in Chinese patients with hyperthyroidism. Endocr Res 2004; 30: 205-13.
5. Harper L, Chin L, Daykin J et al. Propylthiouracil and carbimazole associated-antineutrophil cytoplasmic antibodies (ANCA) in patients with Graves' disease. Clin Endocrinol (Oxf) 2004; 60: 671-75.
6. Leger JM, Dancea S, Brunet P, Hauw JJ. Polyneuropathy during treatment with carbimazole. Rev Neurol (Paris) 1984; 140: 652-6.
7. D'Cruz D, Chesser AM, Lightowler C et al. Antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis associated with anti-thyroid drug treatment. Br J Rheumatol 1995; 34: 1090-1.
8. Miller RM, Savige J, Nassis L, Cominos BI. Antineutrophil cytoplasmic antibody (ANCA)-positive cutaneous leucocytoclastic vasculitis associated with antithyroid therapy in Graves' disease. Australas J Dermatol 1998; 39: 96-9.
9. Yazbeck R, Francoual J, Benoit P, Tauveron I, Tchen C, Thieblot P. Carbimazole and leukocytoclastic vasculitis: apropos of a case. Rev Med Interne 1999; 20: 350-2.
10. Day C, Bridger J, Rylance P, Jackson M, Nicholas J, Odum J. Leukocytoclastic vasculitis and interstitial nephritis with carbimazole treatment. Nephrol Dial Transplant 2003; 18: 429-31.
11. ME R. Eosinophilic gastrointestinal disorders. J Allergy Clin Immunol 2004; 113: 11-28.
12. Maeng LLA, Choi KK, Kang CS, Kim KM. Granulomatous gastritis. A clinicopathologic analysis of 18 biopsy cases. Am J Surg Pathol 2004; 28: 941-5.
13. Shapiro JLGJ, Petras RE. A clinicopathologic study of 42 patients with granulomatous gastritis: is there really an "idiopathic" granulomatous gastritis? Am J Surg Pathol 1996; 20: 462-70.
14. Khan MHLR, Tamoney HJ. Isolated granulomatous gastritis. Am J Gastroenterol 1979; 71: 90-4.
15. Fauci AS. The vasculitis syndromes. In: Isselbacher KJ, Braunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL, eds. Harrison's Principles of Internal Medicine, 13th edn. New York: McGraw-Hill, 1994; 1670-79.
16. Masi AT, Hunder GG, Lie JT et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 1990; 33: 1094-1100.
17. Guillevin L, Cohen P, Gayraud M, Lhote F, Jarrousse B, Casassus P. Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients. Medicine (Baltimore) 1999; 78: 26-37.
18. Premaratna R, Saparamadu A, Samarasekera DN, Warren BF, Jewell DP, de Silva HJ. Eosinophilic granulomatous vasculitis mimicking a gastric neoplasmn. Histopathology 1999; 35: 479-81.
19. Iliopoulou A, Giannakopoulos G, Synetos A, Georgiou A, Chalkiadaki A. Leukocytoclastic vasculitis: is propranolol implicated? Pharmacotherapy 2000; 20: 848-50.
20. Sztern B, Salhadin A, Parent D, Jamart S, Sztern-Van Espen A. Purpuric rash after ingestion of lisinopril. Presse Med 1993; 22: 967.
21. Dolman KMGR, Vervaat TJ, Zevenbergen G et al. Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy. Lancet 1993; 342: 651-2.
22. Choi HK, Merkel PA, Walker AM, Niles JL. Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies. Arthritis Rheum 2000; 43: 405-13.
23. Pillinger M, Staud R. Wegener's granulomatosis in a patient receiving propylthiouracil for Graves' disease. Semin Arthritis Rheum 1998; 28: 124-9.
24. Ortega WAF. First report of Churg-Strauss syndrome: case report. Chest 2001; 120s: 335-6.
25. Braham A, Med HM, Rais L, Ghorbel IB, Lamloum M, Miled M. Vascularite à anticorps anticytoplasme de polynuclèaires neutrophiles induite par le benzylthio-uracile. Presse Med 2004; 33: 1331-3.
26. Kaaroud H, Khiari K, Ben Moussa F, Barbouch S, Boussema E, Ben Maiz H. Vasculitis with renal and pulmonary involvement in a patient receiving benzylthiouracil for Graves disease. Rev Med Interne 2002; 23: 857-61.
27. Tieulie N, Huong du LT, Andreu M et al. ANCA associated glomerulonephritis related to benzylthiouracil. Rev Med Interne 2002; 23: 853-6.
28. Case records of the Massachusetts General Hospital N Engl J Med 2001; 345: 981-6.
29. Thong HY, Chu CY, Chiu HC. Methimazole-induced antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis and lupus-like syndrome with a cutaneous feature of vesiculo-bullous systemic lupus erythematosus. Acta Derm Venereol 2002; 82: 206-8.
30. Gunton JE, Stiel J, Caterson RJ, McElduff A. Anti-thyroid drugs and antineutrophil antibody positive vasculitis. A case report and review of the literature. J Clin Endocrinol Metab 1999; 84: 13-6.
31. Noh JY, Asari T, Hamada N et al. Frequency of appearance of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) in Graves' disease patients treated with propylthiouracil and the relationship between MPO-ANCA and clinical manifestations. Clin Endocrinol (Oxf) 2001; 54: 651-4.
32. Mathieu E, Fain O, Sitbon M, Thomas M. Systemic adverse effect of antithyroid drugs. Clin Rheumatol 1999; 18: 66-8.